{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:54:52Z","timestamp":1793379292587,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T00:00:00Z","timestamp":1720310400000},"content-version":"am","delay-in-days":372,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0280"],"award-info":[{"award-number":["W81XWH-20-1-0280"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.chest.2023.01.019","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T10:46:31Z","timestamp":1674297991000},"page":"252-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma"],"prefix":"10.1016","volume":"164","author":[{"given":"Kamran","family":"Mahmood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvathi","family":"Jampani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momen M.","family":"Wahidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral X.","family":"Giovacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2966-3783","authenticated-orcid":false,"given":"Michael","family":"Dorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Shofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Shier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9652-0294","authenticated-orcid":false,"given":"Greg","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott J.","family":"Antonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3971-2964","authenticated-orcid":false,"given":"Andrew B.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.chest.2023.01.019_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/JTO.0b013e318267223a","article-title":"Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer","volume":"7","author":"Morgensztern","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"issue":"4","key":"10.1016\/j.chest.2023.01.019_bib3","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/resp.12496","article-title":"Clinical features and survival of lung cancer patients with pleural effusions","volume":"20","author":"Porcel","year":"2015","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.chest.2023.01.019_bib4","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.21037\/tlcr-21-123","article-title":"Pleural effusions associated with squamous cell lung carcinoma have a low diagnostic yield and a poor prognosis","volume":"10","author":"Dorry","year":"2021","journal-title":"Transl Lung Cancer Res"},{"issue":"10","key":"10.1016\/j.chest.2023.01.019_bib5","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"Mok","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.chest.2023.01.019_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"Zhou","year":"2011","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.chest.2023.01.019_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/LBR.0000000000000534","article-title":"Yield of malignant pleural effusion for detection of oncogenic driver mutations in lung adenocarcinoma","volume":"26","author":"DeMaio","year":"2019","journal-title":"J\u00a0Bronchol Interv Pulmonol"},{"issue":"7","key":"10.1016\/j.chest.2023.01.019_bib8","first-page":"1169","article-title":"Molecular profiling of malignant pleural effusion in metastatic non-small-cell lung carcinoma: the effect of preanalytical factors","volume":"14","author":"Carter","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"10.1016\/j.chest.2023.01.019_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00330-016-4357-8","article-title":"Complication rates of CT-guided transthoracic lung biopsy: meta-analysis","volume":"27","author":"Heerink","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.chest.2023.01.019_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cca.2017.06.007","article-title":"Droplet digital PCR improved the EGFR mutation diagnosis with pleural fluid samples in non-small-cell lung cancer patients","volume":"471","author":"Li","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.chest.2023.01.019_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2021.613071","article-title":"Cell-free DNA from pleural effusion samples: is it right for molecular testing in lung adenocarcinoma?","volume":"27","author":"Mokanszki","year":"2021","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.chest.2023.01.019_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194630","article-title":"Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA","volume":"13","author":"Gale","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2023.01.019_bib13","article-title":"New insights into the role of ribonuclease P protein subunit p30 from tumor to internal reference","volume":"12","author":"Wu","year":"2022","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.chest.2023.01.019_bib14","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00216-015-8458-z","article-title":"DNA copy number concentration measured by digital and droplet digital quantitative PCR using certified reference materials","volume":"407","author":"Corbisier","year":"2015","journal-title":"Anal Bioanal Chem"},{"issue":"1","key":"10.1016\/j.chest.2023.01.019_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69432-x","article-title":"Evaluating the quantity, quality and size distribution of cell-free DNA by multiplex droplet digital PCR","volume":"10","author":"Alcaide","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.chest.2023.01.019_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193802","article-title":"Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling","volume":"13","author":"Plagnol","year":"2018","journal-title":"PLoS One"},{"issue":"19","key":"10.1016\/j.chest.2023.01.019_bib17","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2014.3741","article-title":"Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs","volume":"311","author":"Kris","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.chest.2023.01.019_bib18","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.21037\/jtd.2020.04.20","article-title":"Liquid biopsy is a valuable tool in the diagnosis and management of lung cancer","volume":"12","author":"Cecchini","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"issue":"11","key":"10.1016\/j.chest.2023.01.019_bib19","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.3390\/cells9112486","article-title":"Liquid biopsy of non-plasma body fluids in non-small cell lung cancer: look closer to the tumor","volume":"9","author":"Durin","year":"2020","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.chest.2023.01.019_bib20","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/sj.bjc.6603428","article-title":"EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib","volume":"95","author":"Kimura","year":"2006","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.chest.2023.01.019_bib21","first-page":"8813","article-title":"Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing","volume":"7","author":"Lin","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"10.1016\/j.chest.2023.01.019_bib22","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1002\/cam4.3769","article-title":"Multigene PCR using both cfDNA and cfRNA in the supernatant of pleural effusion achieves accurate and rapid detection of mutations and fusions of driver genes in patients with advanced NSCLC","volume":"10","author":"Chen","year":"2021","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.chest.2023.01.019_bib23","doi-asserted-by":"crossref","first-page":"00016","DOI":"10.1183\/23120541.00016-2019","article-title":"Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions","volume":"5","author":"Hummelink","year":"2019","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.chest.2023.01.019_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01734-2016","article-title":"Molecular biomarkers for lung adenocarcinoma","volume":"49","author":"Calvayrac","year":"2017","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2023.01.019_bib25","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1002\/1878-0261.12574","article-title":"Prospective detection of mutations in cerebrospinal fluid, pleural effusion, and ascites of advanced cancer patients to guide treatment decisions","volume":"13","author":"Villatoro","year":"2019","journal-title":"Mol Oncol"},{"issue":"19","key":"10.1016\/j.chest.2023.01.019_bib26","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.7150\/thno.34070","article-title":"Tumor-derived DNA from pleural effusion supernatant as a promising alternative to tumor tissue in genomic profiling of advanced lung cancer","volume":"9","author":"Tong","year":"2019","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.chest.2023.01.019_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100784","article-title":"Gene alterations in paired supernatants and precipitates from malignant pleural effusions of non-squamous non-small cell lung cancer","volume":"13","author":"Li","year":"2020","journal-title":"Transl Oncol"},{"issue":"4","key":"10.1016\/j.chest.2023.01.019_bib28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1378\/chest.08-2002","article-title":"A\u00a0prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion","volume":"135","author":"Abouzgheib","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.chest.2023.01.019_bib29","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.critrevonc.2019.06.005","article-title":"Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology","volume":"141","author":"Ponti","year":"2019","journal-title":"Crit Rev Oncol Hematol"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223001265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369223001265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:50:54Z","timestamp":1757926254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369223001265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0012369223001265"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2023.01.019","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High Yield of Pleural Cell-Free DNA for Diagnosis of Oncogenic Mutations in Lung Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2023.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}